These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1816459)

  • 1. [Evaluation of the effectiveness of Pentoxifylline in the treatment of retinal vein thrombosis. Preliminary report].
    Poppe E; Grochowski J
    Klin Oczna; 1991 Sep; 93(9):257-8. PubMed ID: 1816459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of retinal vein thrombosis with pentoxifylline: a controlled, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Incandela L; Steigerwalt R; Nicolaides AN; Griffin M; Geroulakos G
    Angiology; 2002; 53 Suppl 1():S35-8. PubMed ID: 11865834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the effectiveness of drugs influencing the microrheological properties of the blood in the treatment of retinal vein thrombosis].
    Mukha AI; Davydova NG; Konde LA; Tartakovskaia AI
    Vestn Oftalmol; 1988; 104(3):60-3. PubMed ID: 3176249
    [No Abstract]   [Full Text] [Related]  

  • 4. Retinal surgery for treatment of central retinal vein occlusion.
    Weiss JN
    Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion.
    Park CH; Scott AW; Fekrat S
    Retina; 2007 Oct; 27(8):1020-5. PubMed ID: 18040238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effectiveness of endovascular laser irradiation of blood in multimodal treatment of retinal vein thrombosis].
    Zakharova IA; Makhmutova TI; Lobeeva NV
    Vestn Oftalmol; 1996; 112(5):17-9. PubMed ID: 9148556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
    Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
    Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
    Weiss JN
    Am J Ophthalmol; 1998 Jul; 126(1):142-4. PubMed ID: 9683166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome.
    Aggermann T; Haas P; Binder S
    J Neuroophthalmol; 2007 Sep; 27(3):240-1. PubMed ID: 17895826
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
    Cortinovis A; Crippa A; Crippa M
    Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
    Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
    Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
    Feltgen N; Junker B; Agostini H; Hansen LL
    Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell deformability in patients with cerebral vasospasm.
    Sakai T; Okada J; Hara M; Ogashiwa M; Takeuchi K
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):79-82. PubMed ID: 3988398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results and indications for drug therapy in arterial and venous vascular occlusions of the retina due to erythrosclerosis].
    Gallasch G
    Fortschr Ophthalmol; 1985; 82(1):102-4. PubMed ID: 3996983
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial.
    Thomson GJ; Thomson S; Todd AS; Vohra RK; Carr MH; Walker MG
    Int Angiol; 1990; 9(4):266-70. PubMed ID: 2099961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful anticoagulation for bilateral central retinal vein occlusion.
    Glueck CJ; Hutchins RK; Khan A; Bains PS; Khan N; Wang P
    Clin Chim Acta; 2011 May; 412(11-12):1165-6. PubMed ID: 21354124
    [No Abstract]   [Full Text] [Related]  

  • 17. [An update on the treatment of central retinal vein thrombosis (retinal vein occlusion)].
    Iordănescu C; Jurja S
    Oftalmologia; 2000; 50(1):15-8. PubMed ID: 11021101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microcirculatory characteristics in retinal vein thrombosis].
    Lavrik NS
    Oftalmol Zh; 1980; 35(6):334-6. PubMed ID: 7443133
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenetic factors in thrombosis of the central retinal vein].
    Bunin AIa; Mukha AI; Davydova NG; Platonova TK; Markova OA
    Vestn Oftalmol; 1989; 105(6):50-3. PubMed ID: 2617752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pentoxifylline in changes of the statoacoustic apparatus during vascular diseases. Its action on erythrocyte flexibility].
    Pallestrini E; Garaventa G; Cagetti P; Benedetti G; Valle MT; Accomando E; Castiglia G
    Clin Ter; 1986 Aug; 118(4):239-46. PubMed ID: 3489580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.